Live News EQUITY L impact Jun 23, 2026, 12:32 PM UTC

DMAC Starts Phase 2 Trial

DMAC DiaMedica Therapeutics announces first patients dosed in Phase 2 trial of DM199 for the treatment of fetal growth restriction

SQUAWKNEWS Updated Jun 23, 2026, 12:32 PM UTC

DMAC DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction